MBX
MBX Biosciences, Inc.
+1.67 (+2.72%)63.25USD386K成交股數3.0B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 31.0M | 18.5M | 19.8M | 19.3M | 17.7M | 22.4M | 16.7M | 14.4M | 11.0M | – | 9.1M | – |
| 銷售管理費用 | 9.9M | 8.8M | 6.0M | 4.7M | 4.1M | 4.1M | 2.9M | 2.3M | 2.3M | – | 1.9M | – |
| 營業利益 | −40.9M+88% | −27.3M+3% | −25.8M+32% | −23.9M+44% | −21.8M+64% | −26.5M | −19.6M+79% | −16.7M | −13.3M | – | −10.9M | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −37.1M+91% | −23.5M-2% | −22.1M+22% | −21.6M+36% | −19.4M+57% | −23.9M+170% | −18.1M+79% | −15.9M+108% | −12.3M | −8.8M | −10.2M | −7.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.78+34% | -0.50-30% | -0.46-83% | -0.63-95% | -0.58-94% | -0.71 | -2.78-70% | -12.62 | -10.26 | – | -9.40 | – |
| 稀釋股數 | 47.7M | 46.6M | 36.5M | 34.2M | 33.4M | 33.4M | 6.5M | 1.3M | 1.2M | 1.0M | 1.1M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 54.1M | 45.2M | 75.3M | 223M | 39.8M | 29.9M | 133M | – | – | 30.5M | – | – |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 436M | 453M | 385M | 400M | 232M | 246M | 282M | – | – | 84.2M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 26.4M | 14.9M | 15.9M | 12.5M | 12.3M | 10.5M | 11.0M | – | – | 4.3M | – | – |
| 股東權益 | 410M | 438M | 369M | 388M | 219M | 235M | 271M | −97.9M | −83.0M | −72.5M | −64.8M | −55.4M |
| 負債比 | 6.0% | 3.3% | 4.1% | 3.1% | 5.3% | 4.3% | 3.9% | – | – | 5.1% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −20.2M-11% | – | – | – | −22.7M | – | – | −10.7M | – | – | – |
| 資本支出 | – | 437K | – | – | – | 30K | – | – | 273K | – | – | – |
| 自由現金流 | – | −20.6M-9% | – | – | – | −22.7M | – | – | −11.0M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −87.0M | –% | -2.38 | −81.9M |
| FY2024 | – | – | −61.9M | –% | -5.82 | −55.6M |
| FY2023 | – | – | −32.6M | –% | -31.96 | −32.1M |